The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies
Antibiotics · 10.03.2023 · 12 (3) · 554
DOI: 10.3390/antibiotics12030554 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 10.03.2023. Verfasst von Angela França. Beteiligte Einrichtung: Centre of Biological Engineering, LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, Campus de Gualtar, 4710-057 B…. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 347 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, the Portuguese Foundation for Science and Technology (FCT).
Themen: Sepsis
Abstract (Originalsprache)
Infections are one of the most significant complications of neonates, especially those born preterm, with sepsis as one of the principal causes of mortality. Coagulase-negative staphylococci (CoNS), a group of staphylococcal species that naturally inhabit healthy human skin and mucosa, are the most common cause of late-onset sepsis, especially in preterms. One of the risk factors for the development of CoNS infections is the presence of implanted biomedical devices, which are frequently used for medications and/or nutrient delivery, as they serve as a scaffold for biofilm formation. The major concerns related to CoNS infections have to do with the increasing resistance to multiple antibiotics observed among this bacterial group and biofilm cells’ increased tolerance to antibiotics. As such, the treatment of CoNS biofilm-associated infections with antibiotics is increasingly challenging and considering that antibiotics remain the primary form of treatment, this issue will likely persist in upcoming years. For that reason, the development of innovative and efficient therapeutic measures is of utmost importance. This narrative review assesses the current challenges and emerging diagnostic tools and therapies for the treatment of CoNS biofilm-associated infections, with a special focus on late-onset sepsis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre of Biological Engineering, LIBRO-Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
- LABBELS-Associate Laboratory in Biotechnology and Bioengineering and Microelectromechanical Systems, Braga and Guimarães, Portugal.
ORCID-Profile: Angela França
Förderung
- Fundação para a Ciência e Tecnologia
- the Portuguese Foundation for Science and Technology (FCT)
Zitieren
APA
França, A. (2023). The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies. Antibiotics, 12(3), 554. https://doi.org/10.3390/antibiotics12030554
Vancouver
França A. The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies. Antibiotics. 2023;12(3):554. doi:10.3390/antibiotics12030554
BibTeX
@article{Frana2023,
author = {França, Angela},
title = {The Role of Coagulase-Negative Staphylococci Biofilms on Late-Onset Sepsis: Current Challenges and Emerging Diagnostics and Therapies},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {3},
pages = {554},
doi = {10.3390/antibiotics12030554}
}
EUVIMED